ocu400
·Code: NR2E3
ocu400: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Ocugen, Inc. (OCGN) | Phase 3 |
Clinical Trials (1)
An Expanded Access Program for Retinitis Pigmentosa in Adults Aged 18 Years and Older
Frequently asked questions
Who is developing ocu400?
ocu400 is being developed by Ocugen, Inc..
How many clinical trials involve ocu400?
BioSniper tracks 1 clinical trial involving ocu400.
Get deeper analysis on ocu400
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis